Valence Labs

Valence Labs is an AI drug discovery research lab backed by Recursion, developing machine learning methods for molecular discovery.

1. Research focus: It supports R&D acceleration and computational biology rather than guaranteed clinical outcomes, with candidates depending on downstream validation and trials.
2. Best-fit environment: Computational discovery research teams may benefit most when research-first ML aligns with discovery workflows.
3. Engagement model: Access runs through pharma partnerships rather than self-service subscriptions, making data requirements, timelines to validated leads, and collaboration structure considerations.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, while the research-facing model should be weighed against packaged software options.

Valence Labs is best assessed as a research partnership whose fit depends on scientific goals, data access, and collaboration requirements.